Pharmacokinetics-Pharmacodynamics of Enmetazobactam Combined with Cefepime in a Neutropenic Murine Thigh Infection Model
出版年份 2020 全文链接
标题
Pharmacokinetics-Pharmacodynamics of Enmetazobactam Combined with Cefepime in a Neutropenic Murine Thigh Infection Model
作者
关键词
-
出版物
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 64, Issue 6, Pages -
出版商
American Society for Microbiology
发表日期
2020-04-03
DOI
10.1128/aac.00078-20
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- In vitro efficacy of Imipenem-Relebactam and Cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae
- (2020) L. Tselepis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing Klebsiella pneumoniae
- (2020) Adam Johnson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among Enterobacteriaceae Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program
- (2019) Mariana Castanheira et al. Open Forum Infectious Diseases
- Post- MERINO trial: Any role for piperacillin-tazobactam in treating bloodstream infections caused by extended-spectrum beta-lactamase producing Enterobacteriaceae?
- (2019) Maroun M. Sfeir INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Beyond piperacillin-tazobactam: cefepime and AAI101 as a potent β-lactam-β-lactamase inhibitor combination
- (2019) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Generating robust and informative nonclinical in vitro and in vivo bacterial infection model efficacy data to support translation to humans
- (2019) Jürgen B. Bulitta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Considerations for Dose Selection and Clinical Pharmacokinetics/Pharmacodynamics for the Development of Antibacterial Agents
- (2019) M.L. Rizk et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of cefepime-enmetazobactam against Gram-negative isolates collected from United States and European hospitals during 2014-2015
- (2019) Ian Morrissey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients
- (2019) B. Gutiérrez-Gutiérrez et al. CLINICAL MICROBIOLOGY AND INFECTION
- Hypervirulent Klebsiella pneumoniae
- (2019) Thomas A. Russo et al. CLINICAL MICROBIOLOGY REVIEWS
- Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel β-Lactamase Inhibitor Enmetazobactam
- (2019) Adam Belley et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The EMBL-EBI search and sequence analysis tools APIs in 2019
- (2019) Fábio Madeira et al. NUCLEIC ACIDS RESEARCH
- Klebsiella pneumoniae as a key trafficker of drug resistance genes from environmental to clinically important bacteria
- (2018) Kelly L .Wyres et al. CURRENT OPINION IN MICROBIOLOGY
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- Past and Present Perspectives on β-Lactamases
- (2018) Karen Bush ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenem-Sparing Therapy for Extended-Spectrum β-Lactamase–Producing E coli and Klebsiella pneumoniae Bloodstream Infection
- (2018) Mary K. Hayden et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study
- (2018) Elizabeth Temkin et al. Lancet Global Health
- Pharmacokinetics and Pharmacodynamics of β-Lactamase Inhibitors
- (2018) Ryan L. Crass et al. PHARMACOTHERAPY
- Sparing carbapenem usage
- (2017) A. Peter R. Wilson JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacodynamics of Ceftolozane Combined with Tazobactam againstEnterobacteriaceaein a Neutropenic Mouse Thigh Model.
- (2016) M. J. Melchers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparing genome versus proteome-based identification of clinical bacterial isolates
- (2016) Valentina Galata et al. BRIEFINGS IN BIOINFORMATICS
- HGVS Recommendations for the Description of Sequence Variants: 2016 Update
- (2016) Johan T. den Dunnen et al. HUMAN MUTATION
- Klebsiella pneumoniae: Going on the Offense with a Strong Defense
- (2016) Michelle K. Paczosa et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- In VivoActivities of Simulated Human Doses of Cefepime and Cefepime-AAI101 against Multidrug-Resistant Gram-Negative Enterobacteriaceae
- (2015) Jared L. Crandon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Ceftolozane plus Tazobactam Studied in anIn VitroPharmacokinetic Model of Infection
- (2015) Alasdair P. MacGowan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Trends in Susceptibility of Escherichia coli from Intra-Abdominal Infections to Ertapenem and Comparators in the United States According to Data from the SMART Program, 2009 to 2013
- (2015) Sibylle H. Lob et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Ceftolozane in anIn VitroInfection Model
- (2013) Brian VanScoy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Complete Genome Sequence of Klebsiella pneumoniae subsp. pneumoniae HS11286, a Multidrug-Resistant Strain Isolated from Human Sputum
- (2012) P. Liu et al. JOURNAL OF BACTERIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started